SPC134

HPV 52 L1 prótín

  • Status:
    Veitt
  • Application date:
    8.12.2015
  • Application published:
    15.1.2016
  • Grant published:
    15.3.2018
  • Max expiry date:
    17.9.2030
  • Next due date:
    31.3.2027
  • Medicine name:
    Gardasil 9
  • Medicine for children:
    Yes

Timeline

Today
8.12.2015Application
15.1.2016Publication
15.3.2018Registration
17.3.2027Expires

Marketing license

  • IS authorization number:
    EU/1/15/1007/002-003 & EU/1/15/1007/001
  • Date:
    8.7.2015
  • Foreign authorization number:
    EU/1/15/1007/001-003
  • Date:
    10.6.2015

Owner

  • Name:
    Merck Sharp & Dohme LLC
  • Address:
    126 East Lincoln Avenue, Rahway, New Jersey 07065 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 2.1.2025

Expires: 17.3.2026

Payer: Árnason Faktor ehf.

Number: 2

Paid: 12.1.2026

Expires: 17.3.2027

Payer: Árnason Faktor ehf.

Upload documents